Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | PLX-4720 | 0.0033113 | uM | 5 | 5000.00 | 1266.29 | 8040.00 | 7898.50 | 1.0179 | 1.0135 |
| BT-20 | Nilotinib | 0.0033113 | uM | 5 | 5000.00 | 1266.29 | 8159.00 | 7898.50 | 1.0330 | 1.0247 |
| BT-20 | PLX-4720 | 0.31623 | uM | 5 | 5000.00 | 1266.29 | 7652.00 | 7898.50 | 0.9688 | 0.9761 |
| BT-20 | NVP-TAE684 | 0.031623 | uM | 5 | 5000.00 | 1266.29 | 7832.00 | 7898.50 | 0.9916 | 0.9936 |
| BT-20 | Nilotinib | 0.31623 | uM | 5 | 5000.00 | 1266.29 | 7893.00 | 7898.50 | 0.9993 | 0.9995 |
| BT-20 | NVP-TAE684 | 1 | uM | 5 | 5000.00 | 1266.29 | 7193.00 | 7898.50 | 0.9107 | 0.9304 |
| BT-20 | Etoposide | 0.031623 | uM | 5 | 5000.00 | 1266.29 | 7498.00 | 7898.50 | 0.9493 | 0.9610 |
| BT-20 | PLX-4720 | 1 | uM | 5 | 5000.00 | 1266.29 | 7745.00 | 7898.50 | 0.9806 | 0.9852 |
| BT-20 | PLX-4720 | 0.031623 | uM | 5 | 5000.00 | 1266.29 | 7637.00 | 7898.50 | 0.9669 | 0.9747 |
| BT-20 | 0 | uM | 5 | 5000.00 | 1266.29 | 7877.00 | 7898.50 | 0.9973 | 0.9979 | |
| BT-20 | 0 | uM | 5 | 5000.00 | 1266.29 | 7246.00 | 7898.50 | 0.9174 | 0.9358 | |
| BT-20 | 0 | uM | 5 | 5000.00 | 1266.29 | 7682.00 | 7898.50 | 0.9726 | 0.9791 | |
| BT-20 | 0 | uM | 5 | 5000.00 | 1266.29 | 7971.00 | 7898.50 | 1.0092 | 1.0069 | |
| BT-20 | Etoposide | 0.01 | uM | 5 | 5000.00 | 1266.29 | 8182.00 | 7898.50 | 1.0359 | 1.0269 |
| BT-20 | Etoposide | 0.31623 | uM | 5 | 5000.00 | 1266.29 | 7060.00 | 7898.50 | 0.8938 | 0.9168 |
| BT-20 | PLX-4720 | 0.1 | uM | 5 | 5000.00 | 1266.29 | 8279.00 | 7898.50 | 1.0482 | 1.0359 |
| BT-20 | Nilotinib | 0.01 | uM | 5 | 5000.00 | 1266.29 | 8279.00 | 7898.50 | 1.0482 | 1.0359 |
| BT-20 | Nilotinib | 0.1 | uM | 5 | 5000.00 | 1266.29 | 8437.00 | 7898.50 | 1.0682 | 1.0506 |
| BT-20 | Etoposide | 19.9526 | uM | 5 | 5000.00 | 1266.29 | 2774.00 | 7898.50 | 0.3512 | 0.3457 |
| BT-20 | PLX-4720 | 0.01 | uM | 5 | 5000.00 | 1266.29 | 8652.00 | 7898.50 | 1.0954 | 1.0702 |
| BT-20 | PLX-4720 | 3.1623 | uM | 5 | 5000.00 | 1266.29 | 7731.00 | 7898.50 | 0.9788 | 0.9838 |
| BT-20 | Nilotinib | 10 | uM | 5 | 5000.00 | 1266.29 | 3161.00 | 7898.50 | 0.4002 | 0.4140 |
| BT-20 | NVP-TAE684 | 0.0016596 | uM | 5 | 5000.00 | 1266.29 | 8601.00 | 7898.50 | 1.0889 | 1.0656 |
| BT-20 | Nilotinib | 1 | uM | 5 | 5000.00 | 1266.29 | 8177.00 | 7898.50 | 1.0353 | 1.0264 |
| BT-20 | NVP-TAE684 | 0.1 | uM | 5 | 5000.00 | 1266.29 | 8119.00 | 7898.50 | 1.0279 | 1.0210 |